Loading clinical trials...
Loading clinical trials...
Medically stable outpatients receiving chronic oral corticosteroid therapy were enrolled in a 48-week randomized, double-blind, placebo-controlled, parallel-group, trial of lamotrigine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Texas Southwestern Medical Center
Collaborators
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06584357 · Mild Cognitive Impairment, Alzheimer's Disease, and more
NCT05663034 · Traumatic Brain Injury, Insomnia, and more
NCT06930846 · Brain Cancer, Brain Tumor, and more
NCT06951919 · Multiple Sclerosis, Cognitive Dysfunction, and more
Parkland Health and Hospital System (Asthma, Allergy, & Arthritis Clinics)
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions